In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Dr. Christopher Klebanoff
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
MSK endometrial cancer specialists are seen: gynecological surgeon Carol Brown, MD; Carol Aghajanian, MD, Chief of the Gynecological Medical Oncology Service; medical oncologist Ying Liu, MD, MPH; and molecular geneticist Britta Weigelt, PhD.
Endometrial Cancer: New Insights Into a Deadly Disparity

Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
Dr. Lorenzo Falchi
In the Clinic
Blood Test To Identify Which Large B Cell Lymphoma Patients Are Candidates for Glofitamab Shows Promise in Clinical Trial

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).
Anne and Robert Schmiedel
In the Clinic
New Treatment Results for Follicular Lymphoma Clinical Trial Presented at ASH 2023

A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid chemotherapy. Learn more about how it benefited patients who had not yet received other treatments for their lymphoma.
Omar Abdel-Wahab and Salima Benbarche
MSK’s Omar Abdel-Wahab Honored for Research Targeting Blood Cancers

MSK physician-scientist Dr. Omar Abdel-Wahab, is being honored at the 2023 American Society of Hematology (ASH) Annual Meeting with the William Dameshek Prize, which recognizes individuals who have made outstanding contributions to the field of hematology.
Suleika Jaouad is seen in the hallway of MSK with her husband Jon Batiste.
Living Life to the Fullest During Cancer: ‘American Symphony’ Documentary

Learn about life lessons during cancer in the acclaimed documentary "American Symphony," which follows Suleika Jaouad and Jon Batiste’s journey during her bone marrow transplant at Memorial Sloan Kettering.
Dana and John Avellino
FDA Approves Nirogacestat, the First-Ever Targeted Therapy for Desmoid Tumors

The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.